With $10 million from NIMH, GHRI is leading a multi-site study to ensure safe prescribing of antipsychotic drugs for youth with behavioral disorders.
For over a decade, Dr. Michael Von Korff and others have been working on a strategy to stop the opioid epidemic. Here’s an outline.
Three (amazing) Group Health patients tell the stories of participating in our research, and we show what fun it is to work here.
Dr. David Arterburn describes his research on Group Health patients’ weight after 2 years on various antidepressants.
Group Health supports Bike Everywhere in May. Draft off Rob Penfold as he offers tips, ride suggestions, and encouragement.
In our daily lives, we generate a trail of personal data. Dr. Andrea Hartzler is making sure we have a say in how our data are used.
Group Health leaders and national public health experts weighed in on GHRI’s future role in health care. Dr. Eric B. Larson tells what we learned.
Drs. Katharine Bradley and Gwen Lapham studied drinking habits and hospital readmission, noting that underlying social determinants might be the connection.
Dr. David Arterburn reflects on CROSSROADS randomized controlled trial of Group Health patients with obesity and type 2 diabetes.